DeAnne Stolarik

Mechanistic Dissection of PARP1 Trapping and the Impact on <i>In Vivo</i> Tolerability and Efficacy of PARP Inhibitors

Todd A. Hopkins, Yan Shi, Luis E. Rodrı́guez et al. · Molecular Cancer Research · 2015 · 257 citations

Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport

Venecia R. Wilson, Xiaochun Lou, Donald J. Osterling et al. · Journal of Controlled Release · 2018 · 153 citations

Membrane Mass Transport, Diffusion Resistance, Transport Phenomena +6

Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-<i>N</i>-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors

Jeffrey J. Rohde, Marina Pliushchev, Bryan K. Sorensen et al. · Journal of Medicinal Chemistry · 2006 · 76 citations · Full text

Medicinal Chemistry, Pharmacological Study, Biochemistry +11

Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease

Matthew Rosebraugh, Eric A. Voight, Ehab M. Moussa et al. · Annals of Neurology · 2021 · 76 citations · Full text

Adamantane sulfone and sulfonamide 11-β-HSD1 Inhibitors

Bryan K. Sorensen, Martin Winn, Jeff Rohde et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 64 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Adamantane Sulfone +8